Evaluation of a sex-based difference in the pharmacokinetics of digoxin.
about
The safety of digoxin as a pharmacological treatment of atrial fibrillation.Digoxin - a therapeutic agent and mechanistic probe: review of liquid chromatographic mass spectrometric methods and recent nuances in the clinical pharmacology attributes of digoxin.Gender differences in the effects of cardiovascular drugs.Pharmacokinetics and dosing requirements of digoxin in pregnant women treated for fetal supraventricular tachycardia.
P2860
Evaluation of a sex-based difference in the pharmacokinetics of digoxin.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Evaluation of a sex-based difference in the pharmacokinetics of digoxin.
@ast
Evaluation of a sex-based difference in the pharmacokinetics of digoxin.
@en
type
label
Evaluation of a sex-based difference in the pharmacokinetics of digoxin.
@ast
Evaluation of a sex-based difference in the pharmacokinetics of digoxin.
@en
prefLabel
Evaluation of a sex-based difference in the pharmacokinetics of digoxin.
@ast
Evaluation of a sex-based difference in the pharmacokinetics of digoxin.
@en
P2860
P1433
P1476
Evaluation of a sex-based difference in the pharmacokinetics of digoxin.
@en
P2093
Lingtak-Neander Chan
Lois S Lee
P2860
P356
10.1592/PHCO.2006.26.1.44
P407
P577
2006-01-01T00:00:00Z